bioAffinity SAB webinar on CyPath Lung for early lung cancer detection on June 16

bioAffinity Technologies, Inc.

Society for Advanced Bronchoscopy hosts free webinar June 16, 7pm ET on CyPath Lung's role in early lung cancer detection.
Panel includes med onc Vijay Gunuganti, thoracic surgeon Reginald Baptiste, interventional pulmonologist Sai Guda.
CyPath Lung is a noninvasive sputum test using flow cytometry and AI; published trial: 92% sensitivity, 87% specificity, 99% NPV for nodules <20mm.
Webinar to discuss real-world benefits: guiding surgery, reducing unnecessary procedures, supporting surveillance.
CEO Maria Zannes notes collaboration with SAB to advance minimally invasive lung diagnostics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.